David Roger Deyle MD
Clinical Genetics
Assistant Professor, Medical Genetics, Mayo Medical School
Join to View Full Profile
200 1st St SwRochester, MN 55905
Phone+1 507-284-2511
Are you Dr. Deyle?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 1 invite waiting! - Read the latest clinical news, personalized to your specialty.
Summary
- Dr. David Deyle, MD is a board certified medical geneticist in Rochester, Minnesota. He is currently licensed to practice medicine in Minnesota, Arizona, and Florida. He is an Assistant Professor at Mayo Medical School.
Education & Training
University of WashingtonResidency, Medical Genetics and Genomics, 2004 - 2006
University of MinnesotaResidency, Internal Medicine/Pediatrics, 2000 - 2004- University of Minnesota Medical SchoolClass of 2000
Certifications & Licensure
MN State Medical License 2012 - 2025
AZ State Medical License 2016 - 2022
FL State Medical License 2016 - 2020
WA State Medical License 2004 - 2013
American Board of Medical Genetics and Genomics Clinical Genetics and Genomics
Publications & Presentations
PubMed
- An evaluation of practices and policies used in genetics clinics across the United States to manage referrals for Ehlers-Danlos and hypermobility syndromes.Lauren Boucher, Berkley Nestler, Daniel Groepper, John Quillin, David Deyle
Genetics in Medicine Open. 2025-01-01 - Semiautomated approach focused on new genomic information results in time and effort-efficient reannotation of negative exome data.Alejandro Ferrer, Patrick Duffy, Rory J Olson, Michael A Meiners, Laura Schultz-Rogers
Human Genetics. 2024-05-01 - 9 citationsVosoritide Therapy in Children with Achondroplasia: Early Experience and Practical Considerations for Clinical Practice.Oliver Semler, Valérie Cormier-Daire, Ekkehart Lausch, Michael B Bober, Ricki Carroll
Advances in Therapy. 2024-01-01
Press Mentions
Castle Creek Biosciences Expands Its Innovative Gene Therapy Platform for Rare Genetic Connective Tissue Disorders Through Research Collaboration with Mayo ClinicSeptember 29th, 2021- Research Grants Aim to Advance Regenerative Medicine Toward the PracticeJune 29th, 2020
Recombinetics Announces Collaboration with Mayo Clinic to Develop the First-Ever Swine Models of Osteogenesis ImperfectaOctober 7th, 2019- Join now to see all
